SHINE believes that fusion is ultimately the way humanity will produce energy. However, reaching that point requires time, investment, and practical solutions.
For this reason, SHINE adopts a scalable approach that addresses critical challenges at every stage of the process, designing and operating innovative fusion systems for near-term applications such as medical isotope production and the inspection of industrial components.
The steps it is taking today lay the solid foundation for tomorrow’s fusion-based energy world.
What sets SHINE apart from other fusion companies is that it has not only developed its technology but has also commercialized it today and begun scaling it up.
At each stage of its four-phase roadmap, the company perfects the core competencies required for commercially viable fusion, delivers valuable products, generates sustainable returns for its shareholders, and invests in future growth.
As Nukleon, we are proud to serve as the authorized distributor in the Turkish market for SHINE’s NCA (no-carrier-added) Lutetium-177 (Lu-177) product, ILUMIRA.
For more information, you can visit shinefusion.com ↗.